Shining light on Medicare's values
The Medicare physician data release An evidence-policy gap hinders efforts to achieve the triple aim of improving patient care, enhancing population health, and reducing health care costs. 1 To formulate evidence-based policy, the first step is to gather the right data. 2 On April 9, 2014, the Centers for Medicare & Medicaid Services (CMS) publicly released data on $77 billion in Medicare Part B payments for services and procedures that over 880,000 physicians and other health care professionals provided to Medicare beneficiaries in 2012. 3, 4 The information illuminates Medicare's values regarding provider reimbursement and patient care.
In this issue of Neurology ® , Skolarus et al. 5 analyzed the Medicare database to determine how payments to neurologists vary by service type (i.e., evaluation and management [E/M] vs tests/treatments) and compared neurology with other specialties. Fifty-nine percent of Medicare payments to neurologists were for E/M, lower than for primary care providers (approximately 85%) and higher than for surgical subspecialties (range 9%-51%). Twothirds of neurologists received 60% or more of their payment from E/M services, and over 20% received all of their payment from E/M. E/M services are fundamental to making new diagnoses, selecting appropriate diagnostic tests and treatments, and patient follow-up. Incentivizing E/M should help achieve the triple aim. 6 Paradoxically, however, Medicare's Primary Care Incentive Payment Program, part of the 2010 Affordable Care Act, only awards a 10% Medicare bonus payment to certain physicians and other qualified health care professionals if outpatient E/M codes account for at least 60% of their total allowed charges before January 1, 2016. Eligibility is restricted to physicians with Medicare specialty designations of family medicine, geriatric medicine, pediatric medicine, and internal medicine. Two-thirds of neurologists met the 60% E/M threshold in 2012, yet they were excluded from this program. They would have been included if the policy incentivized physicians by what services they provide rather than by specialty. Other specialties that perform a high proportion of E/M services, including psychiatrists and obstetricians/gynecologists, were also excluded and would be natural allies in advocacy efforts to reform E/M incentive programs.
Skolarus et al. probably underestimate the proportion of E/M income most neurologists receive from Medicare after 2012 because reimbursement for EMG and nerve conduction studies-the procedures most commonly performed by neurologists-were cut dramatically in 2013, making neurologists' participation in future E/M incentive plans even more important. Neurologists comprise only 1.5% of individual providers receiving Medicare payments, minimizing any negative budgetary influence from inclusion of neurology in these programs.
Fair and appropriate valuation of E/M services performed by neurologists will remain relevant as health care reimbursement changes from volume-to value-based systems such as accountable care organizations and medical homes. Current misalignments potentially will be carried forward into future valuebased systems since they may be benchmarked according to legacy fee-for-service payments.
The CMS dataset has important limitations. 7 It only includes information on Medicare fee-for-service beneficiaries, so it may not reflect a provider's whole practice, does not include quality measures, and is not riskadjusted. Modifiers, geographic area of service, and other services performed during the same day/visit that can affect payment are not included. The data only represent the physician's professional fee for services delivered in a facility, not the facility fee. The dataset does not account for the payer's purchase price of the drug when a provider administers drugs to a patient. If a physician bills as a representative of a larger group, the payments are listed as going only to that physician.
Beyond neurologists, the study has critical implications for older Americans with neurologic disorders. Currently, approximately 0.5 million Americans have Parkinson disease, 2 million have epilepsy, and 5 million have Alzheimer disease. With the aging of the US population, these numbers will increase, and in some cases double over the next generation. Medicare's reimbursement policies affect the care that these individuals and their families, which will soon include most of us, receive.
The data and analysis conducted provide robust evidence that Medicare is spending taxpayer dollars on facilities and procedures and not on the care of beneficiaries. A large and increasing amount of Medicare part B payments goes to facilities. 8 For example, Medicare (and Medicare beneficiaries) pays approximately $104 for a level 4 follow-up visit in a community-based clinic but 64% more or $171 if in a hospital-based facility. The facility fee for an EEG is $170, more than a neurologist receives for diagnosing and caring for someone with epilepsy. Facility fees distort care and even reduce physician autonomy by fueling the employment of physicians by hospitals that benefit from the fees. 8 Consequently, Medicare's reimbursement policies incentivize high-cost, institutional care that most beneficiaries and most of society want to move away from.
In 1965, when Medicare was created, nearly half of older Americans could not access care. While Medicare has protected older Americans from large catastrophic health care costs, it has largely failed to ensure that beneficiaries with chronic conditions receive appropriate care. Today, over 40% of Medicare beneficiaries with Parkinson disease do not see a neurologist, and those who do not are 20% more likely to fracture a hip, be placed in a skilled nursing facility, and to die. 9 While distance and disability are likely contributors, economic factors cannot be overlooked. 10 Medicare's current policies, which do not even give token representation to Medicare beneficiaries, do not reflect the values of Medicare beneficiaries, some of whom have now contributed to the program for half a century. Absent fundamental changes in these reimbursement policies (e.g., doubling E/M reimbursement, eliminating facility fees, incentivizing home care), beneficiaries will increasingly receive services that Medicare pays for and not services that Medicare beneficiaries need or want. Like 50 years ago, these changes will come not from physicians but from current and future beneficiaries who have the most to gain and the most to lose.
